THE GRÜNENTHAL GROUP
Grünenthal is an independent, research-based, pharmaceutical company with international operations. It has been under family-ownership since its foundation in 1946. Grünenthal's products are marketed in more than 80 countries, and the number of subsidiaries is growing constantly. In the meantime Grünenthal employs round about 4,800 people world-wide, who have made a great contribution to the company's success.
Future consolidation by means of innovative research is an integral part of our company policy. Grünenthal's ambition is to be a leading R&D company in selected indications: pain is our core competence.
